Pfizer cites positive results on migraine treatment
US pharmaceutical giant Pfizer has obtained positive results in late-stage testing for a nasal spray designed to treat migraines, a study showed Thursday.
Feb 16, 2023
0
19
US pharmaceutical giant Pfizer has obtained positive results in late-stage testing for a nasal spray designed to treat migraines, a study showed Thursday.
Feb 16, 2023
0
19
Epigenetic age, a robust marker of biological aging, has been associated with obesity, low-grade inflammation and metabolic diseases. However, few studies have examined associations between different epigenetic age measures ...
Feb 16, 2023
0
4
Adolescents who feel a greater sense of purpose may be happier and more satisfied with life than peers who feel less purposeful, suggests a recent study of more than 200 teens.
Feb 13, 2023
0
26
Using activity-monitoring devices and mobile applications helps improve the physical activity and health outcomes of patients undertaking cardiac rehabilitation programs, according to new research from Flinders University's ...
Feb 9, 2023
0
2
Universitätsmedizin Berlin, the Max Planck Institute for Molecular Genetics (MPIMG), and the University Hospital Schleswig-Holstein (UKSH) have investigated in detail how BPTA syndrome, an extremely rare hereditary condition, ...
Feb 8, 2023
0
25
Autism detection using electronic health record (EHR) data achieves clinically meaningful accuracy by age 30 days, which improves by age 1 year, according to a study published online Feb. 2 in JAMA Network Open.
Feb 6, 2023
0
2
People from the poorest backgrounds are far more likely to develop a mental disorder later in life than those from wealthier beginnings, suggests a study published online in the Journal of Epidemiology & Community Health.
Feb 6, 2023
0
2
At a time of devastating grief, family members of facial transplant donors face a range of difficult challenges—from the unexpected donation request, to unique issues related to the donor's identity, to an onslaught of ...
Feb 6, 2023
0
15
A recent study from UiB shows that elevated plasma methylmalonic acid predicts increased risk of acute myocardial infarction and mortality in patients with suspected or verified coronary heart disease.
Feb 3, 2023
0
9
A new microfluidic device developed by scientists in Switzerland can detect the SARS-CoV-2 virus with high accuracy and speed, using a unique DNA/RNA duplex technology. The device could prove to be a game-changer in the fight ...
Feb 2, 2023
0
7